{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T10:13:38Z","timestamp":1789899218990,"version":"4.0.1"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,9,12]],"date-time":"2016-09-12T00:00:00Z","timestamp":1473638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,9,12]],"date-time":"2016-09-12T00:00:00Z","timestamp":1473638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1038\/bmt.2016.154","type":"journal-article","created":{"date-parts":[[2016,9,12]],"date-time":"2016-09-12T13:43:25Z","timestamp":1473687805000},"page":"1549-1555","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Striving to cure adult T-cell leukaemia\/lymphoma: a role for allogeneic stem cell transplant?"],"prefix":"10.1038","volume":"51","author":[{"given":"E H","family":"Phillips","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Hodson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Hermine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Bazarbachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Cwynarski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,12]]},"reference":[{"key":"BFbmt2016154_CR1","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1073\/pnas.79.6.2031","volume":"79","author":"M Yoshida","year":"1982","unstructured":"Yoshida M, Miyoshi I, Hinuma Y . Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 1982; 79: 2031\u20132035.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFbmt2016154_CR2","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1097\/00042560-199600001-00005","volume":"13","author":"B Hanchard","year":"1996","unstructured":"Hanchard B . Adult T-cell leukemia\/lymphoma in Jamaica: 1986-1995. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13: S20\u2013S25.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"BFbmt2016154_CR3","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/ijc.2910450206","volume":"45","author":"K Tajima","year":"1990","unstructured":"Tajima K . The 4th nation-wide study of adult T-cell leukemia\/lymphoma (ATL) in Japan: estimates of risk of ATL and its geographical and clinical features. The T- and B-cell Malignancy Study Group. Int J Cancer 1990; 45: 237\u2013243.","journal-title":"Int J Cancer"},{"key":"BFbmt2016154_CR4","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1023\/A:1008265532487","volume":"9","author":"JR Anderson","year":"1998","unstructured":"Anderson JR, Armitage JO, Weisenburger DD . Epidemiology of the non-Hodgkin\u2019s lymphomas: distributions of the major subtypes differ by geographic locations. Ann Oncol 1998; 9: 717\u2013720.","journal-title":"Ann Oncol"},{"key":"BFbmt2016154_CR5","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"JM Vose","year":"2008","unstructured":"Vose JM, Neumann M, Harris ME . International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes international T-cell lymphoma project. J Clin Oncol 2008; 26: 4124\u20134130.","journal-title":"J Clin Oncol"},{"key":"BFbmt2016154_CR6","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","volume":"79","author":"M Shimoyama","year":"1991","unstructured":"Shimoyama M . Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br J Haematol 1991; 79: 428\u2013437.","journal-title":"Br J Haematol"},{"key":"BFbmt2016154_CR7","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1182\/blood-2015-03-632489","volume":"126","author":"H Katsuya","year":"2015","unstructured":"Katsuya H, Ishitsuka K, Utsunomiya A, Hanada S, Eto T, Moriuchi Y et al. Treatment and survival among 1594 patients with ATL diagnosed in the 2000s: a report from the ATL-PI project performed in Japan. Blood 2015; 126: 2570\u20132577.","journal-title":"Blood"},{"key":"BFbmt2016154_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0145-2126(91)90087-A","volume":"15","author":"M Shimoyama","year":"1991","unstructured":"Shimoyama M, Takatsuki K, Araki K, Ichimaru M, Hanada S, Matsumoto M et al. Major prognostic factors of patients with adult T-cell leukemia-lymphoma: a cooperative study. Lymphoma Study Group (1984-1987). Leuk Res 1991; 15: 81\u201390.","journal-title":"Leuk Res"},{"key":"BFbmt2016154_CR9","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1182\/blood.V79.2.477.477","volume":"79","author":"A Sakashita","year":"1992","unstructured":"Sakashita A, Hattori T, Miller CW, Suzushima H, Asou N, Takatsuki K et al. Mutations of the p53 gene in adult T-cell leukemia. Blood 1992; 79: 477\u2013480.","journal-title":"Blood"},{"key":"BFbmt2016154_CR10","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.canlet.2005.03.039","volume":"234","author":"M Tawara","year":"2006","unstructured":"Tawara M, Hogerzeil SJ, Yamada Y, Takasaki Y, Soda H, Hasegawa H et al. Impact of p53 aberration on the progression of Adult T-cell Leukemia\/Lymphoma. Cancer Lett 2006; 234: 249\u2013255.","journal-title":"Cancer Lett"},{"key":"BFbmt2016154_CR11","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1200\/JCO.1997.15.5.1778","volume":"15","author":"Y Yamada","year":"1997","unstructured":"Yamada Y, Hatta Y, Murata K, Sugawara K, Ikeda S, Mine M et al. Deletions of p15 and\/or p16 genes as a poor-prognosis factor in adult T-cell leukemia. J Clin Oncol 1997; 15: 1778\u20131785.","journal-title":"J Clin Oncol"},{"key":"BFbmt2016154_CR12","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/bmt.2011.11","volume":"46","author":"H Baldomero","year":"2011","unstructured":"Baldomero H, Gratwohl M, Gratwohl A, Tichelli A, Niederwieser D, Madrigal A et al. The EBMT activity survey 2009: trends over the past 5 years. Bone Marrow Transplant 2011; 46: 485\u2013501.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016154_CR13","doi-asserted-by":"publisher","first-page":"5458","DOI":"10.1200\/JCO.2007.11.9958","volume":"25","author":"K Tsukasaki","year":"2007","unstructured":"Tsukasaki K, Utsunomiya A, Fukuda H, Shibata T, Fukushima T, Takatsuka Y et al. VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group study JCOG9801. J Clin Oncol 2007; 25: 5458\u20135464.","journal-title":"J Clin Oncol"},{"key":"BFbmt2016154_CR14","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1046\/j.1365-2141.2001.02737.x","volume":"113","author":"Y Yamada","year":"2001","unstructured":"Yamada Y, Tomonaga M, Fukuda H, Hanada S, Utsunomiya A, Tara M et al. A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303. Br J Haematol 2001; 113: 375\u2013382.","journal-title":"Br J Haematol"},{"key":"BFbmt2016154_CR15","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1182\/blood-2006-01-0067","volume":"108","author":"A Datta","year":"2006","unstructured":"Datta A, Bellon M, Sinha-Datta U, Bazarbachi A, Lepelletier Y, Canioni D et al. Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence. Blood 2006; 108: 1021\u20131029.","journal-title":"Blood"},{"key":"BFbmt2016154_CR16","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1182\/blood.V76.10.2065.2065","volume":"76","author":"Y Kuwazuru","year":"1990","unstructured":"Kuwazuru Y, Hanada S, Furukawa T, Yoshimura A, Sumizawa T, Utsunomiya A et al. Expression of P-glycoprotein in adult T-cell leukemia cells. Blood 1990; 76: 2065\u20132071.","journal-title":"Blood"},{"key":"BFbmt2016154_CR17","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1182\/blood.V98.4.1160","volume":"98","author":"N Ohno","year":"2001","unstructured":"Ohno N, Tani A, Uozumi K, Hanada S, Furukawa T, Akiba S et al. Expression of functional lung resistance-related protein predicts poor outcome in adult T-cell leukemia. Blood 2001; 98: 1160\u20131165.","journal-title":"Blood"},{"key":"BFbmt2016154_CR18","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/bjh.13338","volume":"169","author":"T Ishida","year":"2015","unstructured":"Ishida T, Jo T, Takemoto S, Suzushima H, Uozumi K, Yamamoto K et al. Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study. Br J Haematol 2015; 169: 672\u2013682.","journal-title":"Br J Haematol"},{"key":"BFbmt2016154_CR19","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1182\/blood-2011-03-345702","volume":"118","author":"A Bazarbachi","year":"2011","unstructured":"Bazarbachi A, Suarez F, Fields P, Hermine O . How I treat adult T-cell leukemia\/lymphoma. Blood 2011; 118: 1736\u20131745.","journal-title":"Blood"},{"key":"BFbmt2016154_CR20","doi-asserted-by":"publisher","first-page":"4177","DOI":"10.1200\/JCO.2010.28.0669","volume":"28","author":"A Bazarbachi","year":"2010","unstructured":"Bazarbachi A, Plumelle Y, Ramos JC, Tortevoye P, Otrock Z, Taylor G et al. Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia\/lymphoma showing improved survival in the leukemic subtypes. J Clin Oncol 2010; 28: 4177\u20134183.","journal-title":"J Clin Oncol"},{"key":"BFbmt2016154_CR21","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1056\/NEJM199506293322603","volume":"332","author":"P Gill","year":"1995","unstructured":"Gill P, Harrington W, Kaplan M, Ribeiro R, Bennett J, Liebman H et al. Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. N Engl J Med 1995; 332: 1744\u20131748.","journal-title":"N Engl J Med"},{"key":"BFbmt2016154_CR22","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1046\/j.1365-2141.2001.02794.x","volume":"113","author":"E Matutes","year":"2001","unstructured":"Matutes E, Taylor GP, Cavenagh J, Pagliuca A, Bareford D, Domingo A et al. Interferon \u03b1 and zidovudine therapy in adult T-cell leukaemia lymphoma: response and outcome in 15 patients. Br J Haematol 2001; 113: 779\u2013784.","journal-title":"Br J Haematol"},{"key":"BFbmt2016154_CR23","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1056\/NEJM199506293322604","volume":"332","author":"O Hermine","year":"1995","unstructured":"Hermine O, Bouscary D, Gessain A, Turlure P, Leblond V, Franck N et al. Brief report: treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa. N Engl J Med 1995; 332: 1749\u20131751.","journal-title":"N Engl J Med"},{"key":"BFbmt2016154_CR24","doi-asserted-by":"publisher","first-page":"4696","DOI":"10.1200\/JCO.2011.35.5578","volume":"29","author":"A Hodson","year":"2011","unstructured":"Hodson A, Crichton S, Montoto S, Mir N, Matutes E, Cwynarski K et al. Use of zidovudine and interferon alfa with chemotherapy improves survival in both acute and lymphoma subtypes of adult T-cell leukemia\/lymphoma. J Clin Oncol 2011; 29: 4696\u20134701.","journal-title":"J Clin Oncol"},{"key":"BFbmt2016154_CR25","doi-asserted-by":"publisher","first-page":"6528","DOI":"10.1182\/blood-2009-03-211821","volume":"113","author":"G Kchour","year":"2009","unstructured":"Kchour G, Tarhini M, Kooshyar M-M, El Hajj H, Wattel E, Mahmoudi M et al. Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia\/lymphoma (ATL). Blood 2009; 113: 6528\u20136532.","journal-title":"Blood"},{"key":"BFbmt2016154_CR26","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/sj.thj.6200374","volume":"5","author":"O Hermine","year":"2004","unstructured":"Hermine O, Dombret H, Poupon J, Arnulf B, Lefr\u00e8re F, Rousselot P et al. Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed\/refractory adult T-cell leukemia\/lymphoma. Hematol J 2004; 5: 130\u2013134.","journal-title":"Hematol J"},{"key":"BFbmt2016154_CR27","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S2352-3026(15)00284-7","volume":"3","author":"M Ogura","year":"2016","unstructured":"Ogura M, Imaizumi Y, Uike N, Asou N, Utsunomiya A, Uchida T et al. Lenalidomide in relapsed adult T-cell leukaemia-lymphoma or peripheral T-cell lymphoma (ATLL-001): a phase 1, multicentre, dose-escalation study. Lancet Haematol 2016; 3: 107\u2013118.","journal-title":"Lancet Haematol"},{"key":"BFbmt2016154_CR28","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/sj.onc.1208212","volume":"24","author":"R Nasr","year":"2005","unstructured":"Nasr R, El-Sabban ME, Karam J-A, Dbaibo G, Kfoury Y, Arnulf B et al. Efficacy and mechanism of action of the proteasome inhibitor PS-341 in T-cell lymphomas and HTLV-I associated adult T-cell leukemia\/lymphoma. Oncogene 2005; 24: 419\u2013430.","journal-title":"Oncogene"},{"key":"BFbmt2016154_CR29","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1111\/cas.12735","volume":"106","author":"K Ishitsuka","year":"2015","unstructured":"Ishitsuka K, Utsunomiya A, Katsuya H, Takeuchi S, Takatsuka Y, Hidaka M et al. A phase II study of bortezomib in patients with relapsed or refractory aggressive adult T-cell leukemia\/lymphoma. Cancer Sci 2015; 106: 1219\u20131223.","journal-title":"Cancer Sci"},{"key":"BFbmt2016154_CR30","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/leu.2014.241","volume":"29","author":"P Yu","year":"2015","unstructured":"Yu P, Petrus M, Ju W, Zhang M, Conlon K, Nakagawa M et al. Augmented efficacy with the combination of blockade of the Notch-1 pathway, bortezomib and romidepsin in a murine MT-1 adult T-cell leukemia model. Leukemia 2015; 29: 556\u2013566.","journal-title":"Leukemia"},{"key":"BFbmt2016154_CR31","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1200\/JCO.2011.37.3472","volume":"30","author":"T Ishida","year":"2012","unstructured":"Ishida T, Joh T, Uike N, Yamamoto K, Utsunomiya A, Yoshida S et al. Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: A multicenter phase II study. J Clin Oncol 2012; 30: 837\u2013842.","journal-title":"J Clin Oncol"},{"key":"BFbmt2016154_CR32","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.clim.2014.09.012","volume":"155","author":"JL Berkowitz","year":"2014","unstructured":"Berkowitz JL, Janik JE, Stewart DM, Jaffe ES, Stetler-Stevenson M, Shih JH et al. Safety, efficacy, and pharmacokinetics\/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia\/lymphoma. Clin Immunol 2014; 155: 176\u2013187.","journal-title":"Clin Immunol"},{"key":"BFbmt2016154_CR33","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.leukres.2011.12.004","volume":"36","author":"MM Ceesay","year":"2012","unstructured":"Ceesay MM, Matutes E, Taylor GP, Fields P, Cavenagh J, Simpson S et al. Phase II study on combination therapy with CHOP-Zenapax for HTLV-I associated adult T-cell leukaemia\/lymphoma (ATLL). Leuk Res 2012; 36: 857\u2013861.","journal-title":"Leuk Res"},{"key":"BFbmt2016154_CR34","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.1182\/blood-2005-01-0335","volume":"106","author":"A Mone","year":"2005","unstructured":"Mone A, Puhalla S, Whitman S, Baiocchi RA, Cruz J, Vukosavljevic T et al. Durable hematologic complete response and suppression of HTLV-1 viral load following alemtuzumab in zidovudine\/IFN-\u03b1-refractory adult T-cell leukemia. Blood 2005; 106: 3380\u20133382.","journal-title":"Blood"},{"key":"BFbmt2016154_CR35","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1182\/blood-2012-05-427773","volume":"121","author":"J Chen","year":"2013","unstructured":"Chen J, Pise-Masison CA, Shih JH, Morris JC, Janik JE, Conlon KC et al. Markedly additive antitumor activity with the combination of a selective survivin suppressant YM155 and alemtuzumab in adult T-cell leukemia. Blood 2013; 121: 2029\u20132037.","journal-title":"Blood"},{"key":"BFbmt2016154_CR36","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/1742-4690-10-91","volume":"10","author":"G Kchour","year":"2013","unstructured":"Kchour G, Rezaee R, Farid R, Ghantous A, Rafatpanah H, Tarhini M et al. The combination of arsenic, interferon-alpha, and zidovudine restores an \u2018immunocompetent-like\u2019 cytokine expression profile in patients with adult T-cell leukemia lymphoma. Retrovirology 2013; 10: 91.","journal-title":"Retrovirology"},{"key":"BFbmt2016154_CR37","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1084\/jem.20101095","volume":"207","author":"H El Hajj","year":"2010","unstructured":"El Hajj H, El-Sabban M, Hasegawa H, Zaatari G, Ablain J, Saab ST et al. Therapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemia. J Exp Med 2010; 207: 2785\u20132792.","journal-title":"J Exp Med"},{"key":"BFbmt2016154_CR38","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.bbmt.2014.12.020","volume":"21","author":"H Kawada","year":"2015","unstructured":"Kawada H, Yoshimitsu M, Nakamura D, Arai A, Hayashida M, Kamada Y et al. A Retrospective Analysis of treatment outcomes in adult T cell leukemia\/lymphoma patients with aggressive disease treated with or without allogeneic stem cell transplantation: a single-center experience. Biol Blood Marrow Transplant 2015; 21: 696\u2013700.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2016154_CR39","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/sj.bmt.1701533","volume":"23","author":"K Tsukasaki","year":"1999","unstructured":"Tsukasaki K, Maeda T, Arimura K, Taguchi J, Fukushima T, Miyazaki Y et al. Poor outcome of autologous stem cell transplantation for adult T cell leukemia\/lymphoma: a case report and review of the literature. Bone Marrow Transplant 1999; 23: 87\u201389.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016154_CR40","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1080\/10428190902887571","volume":"50","author":"A Phillips","year":"2009","unstructured":"Phillips A, Willim R, Savage D, Horwitz S, Isola L, Zain J et al. A multi-institutional experience of autologous stem cell transplantation in North American patients with human T-cell lymphotropic virus type-1 adult T-cell leukemia\/lymphoma suggests ineffective salvage of relapsed patients. Leuk Lymphoma 2009; 50: 1039\u20131042.","journal-title":"Leuk Lymphoma"},{"key":"BFbmt2016154_CR41","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1038\/bmt.2014.143","volume":"49","author":"A Bazarbachi","year":"2014","unstructured":"Bazarbachi A, Cwynarski K, Boumendil A, Finel H, Fields P, Raj K et al. Outcome of patients with HTLV-1-associated adult T-cell leukemia\/lymphoma after SCT: a retrospective study by the EBMT LWP. Bone Marrow Transplant 2014; 49: 1266\u20131268.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016154_CR42","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1080\/10428190500233244","volume":"46","author":"E Ohno","year":"2005","unstructured":"Ohno E, Ono K, Kikuchi H, Saburi Y, Utsunomiya A, Nasu M . Prolonged remission of adult T-cell leukemia\/lymphoma treated with interferon-gamma following autologous peripheral blood stem cell transplantation. Leuk Lymphoma 2005; 46: 1843\u20131845.","journal-title":"Leuk Lymphoma"},{"key":"BFbmt2016154_CR43","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1159\/000058317","volume":"107","author":"H Fujiwara","year":"2002","unstructured":"Fujiwara H, Arima N, Akasaki Y, Ohtsubo H, Ozaki A, Kukita T et al. Interferon-alpha therapy following autologous peripheral blood stem cell transplantation for adult T cell leukemia\/lymphoma. Acta Haematol 2002; 107: 213\u2013219.","journal-title":"Acta Haematol"},{"key":"BFbmt2016154_CR44","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1182\/blood-2009-10-247510","volume":"116","author":"M Hishizawa","year":"2010","unstructured":"Hishizawa M, Kanda J, Utsunomiya A, Taniguchi S, Eto T, Moriuchi Y et al. Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study. Blood 2010; 116: 1369\u20131376.","journal-title":"Blood"},{"key":"BFbmt2016154_CR45","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1080\/10428190600625042","volume":"47","author":"E Tholouli","year":"2006","unstructured":"Tholouli E, Liu Yin JA . Successful treatment of HTLV-1-associated acute adult T-cell leukemia lymphoma by allogeneic bone marrow transplantation: a 12 year follow-up. Leuk Lymphoma 2006; 47: 1691\u20131692.","journal-title":"Leuk Lymphoma"},{"key":"BFbmt2016154_CR46","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/bmt.2010.92","volume":"46","author":"I Choi","year":"2011","unstructured":"Choi I, Tanosaki R, Uike N, Utsunomiya A, Tomonaga M, Harada M et al. Long-term outcomes after hematopoietic SCT for adult T-cell leukemia\/lymphoma: results of prospective trials. Bone Marrow Transplant 2011; 46: 116\u2013118.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016154_CR47","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1182\/blood-2012-03-414490","volume":"120","author":"T Ishida","year":"2012","unstructured":"Ishida T, Hishizawa M, Kato K, Tanosaki R, Fukuda T, Taniguchi S et al. Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma with special emphasis on preconditioning regimen: a nationwide retrospective study. Blood 2012; 120: 1734\u20131741.","journal-title":"Blood"},{"key":"BFbmt2016154_CR48","first-page":"235","volume":"15","author":"Y Morishima","year":"1995","unstructured":"Morishima Y, Kodera Y, Hirabayashi N, Tanimoto M, Matsuyama T, Horibe K et al. Low incidence of acute GVHD in patients transplanted with marrow from HLA-A,B,DR-compatible unrelated donors among Japanese. Bone Marrow Transplant 1995; 15: 235\u2013239.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016154_CR49","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/j.bbmt.2013.09.014","volume":"19","author":"T Ishida","year":"2013","unstructured":"Ishida T, Hishizawa M, Kato K, Tanosaki R, Fukuda T, Takatsuka Y et al. Impact of graft-versus-host disease on allogeneic hematopoietic cell transplantation for adult T cell leukemia-lymphoma focusing on preconditioning regimens: nationwide retrospective study. Biol Blood Marrow Transplant 2013; 19: 1731\u20131739.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2016154_CR50","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/bmt.2015.265","volume":"51","author":"S Fuji","year":"2016","unstructured":"Fuji S, Fujiwara H, Nakano N, Wake A, Inoue Y, Fukuda T et al. Early application of related SCT might improve clinical outcome in adult T-cell leukemia\/lymphoma. Bone Marrow Transplant 2016; 51: 205\u2013211.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016154_CR51","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.bbmt.2014.02.014","volume":"20","author":"A Shigematsu","year":"2014","unstructured":"Shigematsu A, Kobayashi N, Yasui H, Shindo M, Kakinoki Y, Koda K et al. High level of serum soluble interleukin-2 receptor at transplantation predicts poor outcome of allogeneic stem cell transplantation for adult t cell leukemia. Biol Blood Marrow Transplant 2014; 20: 801\u2013805.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2016154_CR52","doi-asserted-by":"publisher","first-page":"4143","DOI":"10.1182\/blood-2004-11-4193","volume":"105","author":"J Okamura","year":"2005","unstructured":"Okamura J, Utsunomiya A, Tanosaki R, Uike N, Sonoda S, Kannagi M et al. Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia\/lymphoma. Blood 2005; 105: 4143\u20134145.","journal-title":"Blood"},{"key":"BFbmt2016154_CR53","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.bbmt.2008.03.010","volume":"14","author":"R Tanosaki","year":"2008","unstructured":"Tanosaki R, Uike N, Utsunomiya A, Saburi Y, Masuda M, Tomonaga M et al. Allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning for adult T cell leukemia\/lymphoma: impact of antithymocyte globulin on clinical outcome. Biol Blood Marrow Transplant 2008; 14: 702\u2013708.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2016154_CR54","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1111\/j.1349-7006.1990.tb02662.x","volume":"81","author":"S Momita","year":"1990","unstructured":"Momita S, Ikeda S, Amagasaki T, Soda H, Yamada Y, Kamihira S et al. Survey of anti-human T-cell leukemia virus type I antibody in family members of patients with adult T-cell leukemia. Japanese J Cancer Res 1990; 81: 884\u2013889.","journal-title":"Japanese J Cancer Res"},{"key":"BFbmt2016154_CR55","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1056\/NEJMc053295","volume":"354","author":"H Tamaki","year":"2006","unstructured":"Tamaki H, Matsuoka M . Donor-derived T-cell leukemia after bone marrow transplantation. N Engl J Med 2006; 354: 1758\u20131759.","journal-title":"N Engl J Med"},{"key":"BFbmt2016154_CR56","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/S0140-6736(11)60315-2","volume":"377","author":"A Nakamizo","year":"2011","unstructured":"Nakamizo A, Akagi Y, Amano T, Suzuki SO, Otsuka R, Abe Y et al. Donor-derived adult T-cell leukaemia. Lancet 2011; 377: 1124.","journal-title":"Lancet"},{"key":"BFbmt2016154_CR57","unstructured":"Anthony Nolan and NHS Blood and Transplant. Together for Better-Anthony Nolan and NHS Stem Cell Registry Annual Review 2014. http:\/\/www.nhsbt.nhs.uk\/download\/news_110314.pdf."},{"key":"BFbmt2016154_CR58","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1182\/blood-2003-03-0937","volume":"103","author":"K Izutsu","year":"2004","unstructured":"Izutsu K, Kanda Y, Ohno H, Sao H, Ogawa H, Miyazaki Y et al. Unrelated bone marrow transplantation for non-Hodgkin lymphoma: a study from the Japan Marrow Donor Program. Blood 2004; 103: 1955\u20131960.","journal-title":"Blood"},{"key":"BFbmt2016154_CR59","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/sj.bmt.1705197","volume":"37","author":"K Nakase","year":"2006","unstructured":"Nakase K, Hara M, Kozuka T, Tanimoto K, Nawa Y . Bone marrow transplantation from unrelated donors for patients with adult T-cell leukaemia\/lymphoma. Bone Marrow Transplant 2006; 37: 41\u201344.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016154_CR60","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.bbmt.2006.09.002","volume":"13","author":"K Kato","year":"2007","unstructured":"Kato K, Kanda Y, Eto T, Muta T, Gondo H, Taniguchi S et al. Allogeneic bone marrow transplantation from unrelated human T-cell leukemia virus-I-negative donors for adult T-Cell leukemia\/lymphoma: retrospective analysis of data from the japan marrow donor program. Biol Blood Marrow Transplant 2007; 13: 90\u201399.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2016154_CR61","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/sj.bmt.1704692","volume":"34","author":"K Obama","year":"2004","unstructured":"Obama K, Utsunomiya A, Takatsuka Y, Takemoto Y . Reduced-intensity non-T-cell depleted HLA-haploidentical stem cell transplantation for older patients based on the concept of feto-maternal tolerance. Bone Marrow Transplant 2004; 34: 897\u2013899.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016154_CR62","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/leu.2015.232","volume":"30","author":"O Ringd\u00e9n","year":"2015","unstructured":"Ringd\u00e9n O, Labopin M, Ciceri F, Velardi A, Bacigalupo A, Arcese W et al. Is there a stronger graft-versus-leukemia effect using HLA-haploidentical donors than with HLA-identical siblings? Leukemia 2015; 30: 447\u2013455.","journal-title":"Leukemia"},{"key":"BFbmt2016154_CR63","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.1200\/JCO.2014.60.4777","volume":"33","author":"YL Kasamon","year":"2015","unstructured":"Kasamon YL, Bolanos-Meade J, Prince GT, Tsai H-L, McCurdy SR, Kanakry JA et al. Outcomes of nonmyeloablative HLA-haploidentical blood or marrow transplantation with high-dose post-transplantation cyclophosphamide in older adults. J Clin Oncol 2015; 33: 3152\u20133161.","journal-title":"J Clin Oncol"},{"key":"BFbmt2016154_CR64","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1200\/JCO.2012.44.3523","volume":"31","author":"A Bashey","year":"2013","unstructured":"Bashey A, Zhang X, Sizemore CA, Manion K, Brown S, Holland HK et al. T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation. J Clin Oncol 2013; 31: 1310\u20131316.","journal-title":"J Clin Oncol"},{"key":"BFbmt2016154_CR65","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1080\/10428190701191332","volume":"48","author":"H Narimatsu","year":"2007","unstructured":"Narimatsu H, Murata M, Sugimoto K, Terakura S, Kinoshita T, Naoe T . Successful umbilical cord blood transplantation using a reduced-intensity preparative regimen without total body irradiation and tacrolimus plus methotrexate for prophylaxis of graft-versus-host disease in a patient with adult T-cell leukemia\/lymphoma. Leuk Lymphoma 2007; 48: 841\u2013843.","journal-title":"Leuk Lymphoma"},{"key":"BFbmt2016154_CR66","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/ajh.21042","volume":"82","author":"J Takizawa","year":"2007","unstructured":"Takizawa J, Aoki S, Kurasaki T, Higashimura M, Honma K, Kitajima T et al. Successful treatment of adult T-cell leukemia with unrelated cord blood transplantation. Am J Hematol 2007; 82: 1113\u20131115.","journal-title":"Am J Hematol"},{"key":"BFbmt2016154_CR67","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s12185-013-1307-y","volume":"97","author":"T Fukushima","year":"2013","unstructured":"Fukushima T, Itonaga H, Moriuchi Y, Yoshida S, Taguchi J, Imaizumi Y et al. Feasibility of cord blood transplantation in chemosensitive adult T-cell leukemia\/lymphoma: A retrospective analysis of the nagasaki transplantation network. Int J Hematol 2013; 97: 485\u2013490.","journal-title":"Int J Hematol"},{"key":"BFbmt2016154_CR68","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3324\/haematol.2013.088997","volume":"99","author":"CA Rodrigues","year":"2014","unstructured":"Rodrigues CA, Rocha V, Dreger P, Brunstein C, Sengeloev H, Finke J et al. Alternative donor hematopoietic stem cell transplantation for mature lymphoid malignancies after reduced-intensity conditioning regimen: Similar outcomes with umbilical cord blood and unrelated donor peripheral blood. Haematologica 2014; 99: 370\u2013377.","journal-title":"Haematologica"},{"key":"BFbmt2016154_CR69","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3109\/10428199809059222","volume":"31","author":"K Matsushita","year":"1998","unstructured":"Matsushita K, Arima N . Involvement of granulocyte colony-stimulating factor in proliferation of adult T-cell leukemia cells. Leuk Lymphoma 1998; 31: 295\u2013304.","journal-title":"Leuk Lymphoma"},{"key":"BFbmt2016154_CR70","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1046\/j.1365-2141.1997.d01-2102.x","volume":"96","author":"K Matsushita","year":"1997","unstructured":"Matsushita K, Arima N, Ohtsubo H, Fujiwara H, Hidaka S, Kukita T et al. Granulocyte-colony stimulating factor-induced proliferation of primary adult T-cell leukaemia cells. Br J Haematol 1997; 96: 715\u2013723.","journal-title":"Br J Haematol"},{"key":"BFbmt2016154_CR71","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.bbmt.2013.01.011","volume":"19","author":"H Itonaga","year":"2013","unstructured":"Itonaga H, Taguchi J, Fukushima T, Tsushima H, Sato S, Ando K et al. Distinct clinical features of infectious complications in adult T Cell leukemia\/lymphoma patients after allogeneic hematopoietic stem cell transplantation: a retrospective analysis in the nagasaki transplant group. Biol Blood Marrow Transplant 2013; 19: 607\u2013615.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2016154_CR72","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.bbmt.2008.04.014","volume":"14","author":"S Shiratori","year":"2008","unstructured":"Shiratori S, Yasumoto A, Tanaka J, Shigematsu A, Yamamoto S, Nishio M et al. A retrospective analysis of allogeneic hematopoietic stem cell transplantation for adult T cell leukemia\/lymphoma (ATL): clinical impact of graft-versus-leukemia\/lymphoma effect. Biol Blood Marrow Transplant 2008; 14: 817\u2013823.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2016154_CR73","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1038\/bmt.2008.39","volume":"41","author":"K Yonekura","year":"2008","unstructured":"Yonekura K, Utsunomiya A, Takatsuka Y, Takeuchi S, Tashiro Y, Kanzaki T et al. Graft-versus-adult T-cell leukemia\/lymphoma effect following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2008; 41: 1029\u20131035.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016154_CR74","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1182\/blood-2012-07-444372","volume":"121","author":"H Itonaga","year":"2013","unstructured":"Itonaga H, Tsushima H, Taguchi J, Fukushima T, Taniguchi H, Sato S et al. Treatment of relapsed adult T-cell leukemia\/lymphoma after allogeneic hematopoietic stem cell transplantation: the Nagasaki Transplant Group experience. Blood 2013; 121: 219\u2013225.","journal-title":"Blood"},{"key":"BFbmt2016154_CR75","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s12185-012-1056-3","volume":"95","author":"T Kamimura","year":"2012","unstructured":"Kamimura T, Miyamoto T, Kawano N, Numata A, Ito Y, Chong Y et al. Successful treatment by donor lymphocyte infusion of adult T-cell leukemia\/lymphoma relapse following allogeneic hematopoietic stem cell transplantation. Int J Hematol 2012; 95: 725\u2013730.","journal-title":"Int J Hematol"},{"key":"BFbmt2016154_CR76","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1158\/0008-5472.CAN-03-1452","volume":"64","author":"N Harashima","year":"2004","unstructured":"Harashima N, Kurihara K, Utsunomiya A, Tanosaki R, Hanabuchi S, Masuda M et al. Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation. Cancer Res 2004; 64: 391\u2013399.","journal-title":"Cancer Res"},{"key":"BFbmt2016154_CR77","doi-asserted-by":"publisher","first-page":"940","DOI":"10.4049\/jimmunol.1301952","volume":"192","author":"T Narita","year":"2014","unstructured":"Narita T, Ishida T, Masaki A, Suzuki S, Ito A, Mori F et al. HTLV-1 bZIP factor-specific CD4 T cell responses in adult T cell leukemia\/lymphoma patients after allogeneic hematopoietic stem cell transplantation. J Immunol 2014; 192: 940\u2013947.","journal-title":"J Immunol"},{"key":"BFbmt2016154_CR78","doi-asserted-by":"publisher","first-page":"135","DOI":"10.4049\/jimmunol.1202692","volume":"191","author":"A Masaki","year":"2013","unstructured":"Masaki A, Ishida T, Suzuki S, Ito A, Mori F, Sato F et al. Autologous Tax-specific CTL therapy in a primary adult T cell leukemia\/lymphoma cell-bearing NOD\/Shi-scid, IL-2R\u03b3null mouse model. J Immunol 2013; 191: 135\u2013144.","journal-title":"J Immunol"},{"key":"BFbmt2016154_CR79","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.imlet.2013.12.016","volume":"158","author":"Y Tanaka","year":"2014","unstructured":"Tanaka Y, Yamazaki R, Terasako-Saito K, Nakasone H, Akahoshi Y, Nakano H et al. Universal cytotoxic activity of a HTLV-1 Tax-specific T cell clone from an HLA-A*24:02+ patient with adult T-cell leukemia against a variety of HTLV-I-infected T-cells. Immunol Lett 2014; 158: 120\u2013125.","journal-title":"Immunol Lett"},{"key":"BFbmt2016154_CR80","doi-asserted-by":"publisher","first-page":"10088","DOI":"10.1128\/JVI.79.15.10088-10092.2005","volume":"79","author":"N Harashima","year":"2005","unstructured":"Harashima N, Tanosaki R, Shimizu Y, Kurihara K, Masuda T, Okamura J et al. Identification of two New HLA-A*1101-restricted tax epitopes recognized by cytotoxic T lymphocytes in an adult T-cell leukemia patient after hematopoietic stem cell transplantation. J Virol 2005; 79: 10088\u201310092.","journal-title":"J Virol"},{"key":"BFbmt2016154_CR81","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1182\/blood-2015-04-641118","volume":"126","author":"K Sugata","year":"2015","unstructured":"Sugata K, Yasunaga J, Mitobe Y, Miura M, Miyazato P, Kohara M et al. Protective effect of cytotoxic T lymphocytes targeting HTLV-1 bZIP factor. Blood 2015; 126: 1095\u20131105.","journal-title":"Blood"},{"key":"BFbmt2016154_CR82","doi-asserted-by":"publisher","first-page":"4382","DOI":"10.4049\/jimmunol.1202971","volume":"190","author":"Y Tamai","year":"2013","unstructured":"Tamai Y, Hasegawa A, Takamori A, Sasada A, Tanosaki R, Choi I et al. Potential contribution of a novel Tax epitope-specific CD4+ T cells to graft-versus-Tax effect in adult T cell leukemia patients after allogeneic hematopoietic stem cell transplantation. J Immunol 2013; 190: 4382\u20134392.","journal-title":"J Immunol"},{"key":"BFbmt2016154_CR83","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1007\/s10875-012-9729-5","volume":"32","author":"Y Tanaka","year":"2012","unstructured":"Tanaka Y, Nakasone H, Yamazaki R, Wada H, Ishihara Y, Kawamura K et al. Long-term persistence of limited HTLV-1 Tax-specific cytotoxic T cell clones in a patient with adult T-cell leukemia\/lymphoma after allogeneic stem cell transplantation. J Clin Immunol 2012; 32: 1340\u20131352.","journal-title":"J Clin Immunol"},{"key":"BFbmt2016154_CR84","doi-asserted-by":"publisher","first-page":"4894","DOI":"10.1182\/blood-2012-11-465971","volume":"121","author":"Y Miyazaki","year":"2013","unstructured":"Miyazaki Y, Fujiwara H, Asai H, Ochi F, Ochi T, Azuma T et al. Development of a novel redirected T-cell-based adoptive immunotherapy targeting human telomerase reverse transcriptase for adult T-cell leukemia. Blood 2013; 121: 4894\u20134901.","journal-title":"Blood"},{"key":"BFbmt2016154_CR85","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/bmt.2012.268","volume":"48","author":"Y Ito","year":"2013","unstructured":"Ito Y, Miyamoto T, Chong Y, Aoki T, Kato K, Akashi K et al. Successful treatment with anti-CC chemokine receptor 4 MoAb of relapsed adult T-cell leukemia\/lymphoma after umbilical cord blood transplantation. Bone Marrow Transplant 2013; 48: 998\u2013999.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016154_CR86","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/bmt.2015.315","volume":"51","author":"Y Inoue","year":"2015","unstructured":"Inoue Y, Fuji S, Tanosaki R, Fukuda T . Pretransplant mogamulizumab against ATLL might increase the risk of acute GvHD and non-relapse mortality. Bone Marrow Transplant 2015; 51: 725\u2013727.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016154_CR87","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/bmt.2015.254","volume":"51","author":"S Haji","year":"2016","unstructured":"Haji S, Kiyasu J, Choi I, Suehiro Y, Toyoda K, Tsuda M et al. Administration of an anti-CC chemokine receptor 4 monoclonal antibody, mogamulizumab, before allogeneic bone marrow transplantation for adult T-cell leukemia\/lymphoma. Bone Marrow Transplant 2016; 51: 432\u2013434.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016154_CR88","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1365-2141.1994.tb05040.x","volume":"88","author":"P Ljungman","year":"1994","unstructured":"Ljungman P, Lawler M, Asj\u00f6 B, Bogdanovic G, Karlsson K, Malm C et al. Infection of donor lymphocytes with human T lymphotrophic virus type 1 (HTLV-I) following allogeneic bone marrow transplantation for HTLV-I positive adult T-cell leukaemia. Br J Haematol 1994; 88: 403\u2013405.","journal-title":"Br J Haematol"},{"key":"BFbmt2016154_CR89","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1186\/2193-1801-3-581","volume":"3","author":"T Kawamata","year":"2014","unstructured":"Kawamata T, Ohno N, Sato K, Kobayashi M, Jo N, Yuji K et al. A case of post-transplant adult T-cell leukemia\/lymphoma presenting myelopathy similar to but distinct from human T-cell leukemia virus type I (HTLV- I)-associated myelopathy. Springerplus 2014; 3: 581.","journal-title":"Springerplus"},{"key":"BFbmt2016154_CR90","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1111\/ajt.12849","volume":"14","author":"P Ramanan","year":"2014","unstructured":"Ramanan P, Deziel PJ, Norby SM, Yao JD, Garza I, Razonable RR . Case report donor-transmitted HTLV-1-associated myelopathy in a kidney transplant recipient\u2014case report and literature review. Am J Transplant 2014; 14: 2417\u20132421.","journal-title":"Am J Transplant"},{"key":"BFbmt2016154_CR91","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/sj.bmt.1703702","volume":"30","author":"M Ogata","year":"2002","unstructured":"Ogata M, Ogata Y, Imamura T, Ohtsuka E, Kikuchi H, Utsunomiya A et al. Successful bone marrow transplantation from an unrelated donor in a patient with adult T cell leukemia. Bone Marrow Transplant 2002; 30: 699\u2013701.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016154_CR92","first-page":"290","volume":"71","author":"K Tajima","year":"2000","unstructured":"Tajima K, Amakawa R, Uehira K, Matsumoto N, Shimizu T, Miyazaki Y et al. Adult T-cell leukemia successfully treated with allogeneic bone marrow transplantation. Int J Hematol 2000; 71: 290\u2013293.","journal-title":"Int J Hematol"},{"key":"BFbmt2016154_CR93","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/BF02982725","volume":"76","author":"Y Abe","year":"2002","unstructured":"Abe Y, Yashiki S, Choi I, Hara K, Matsushima T, Nishimura J et al. Eradication of virus-infected T-cells in a case of adult T-cell leukemia\/lymphoma by nonmyeloablative peripheral blood stem cell transplantation with conditioning consisting of low-dose total body irradiation and pentostatin. Int J Hematol 2002; 76: 91\u201393.","journal-title":"Int J Hematol"},{"key":"BFbmt2016154_CR94","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1532\/IJH97.07070","volume":"86","author":"J Okamura","year":"2007","unstructured":"Okamura J, Uike N, Utsunomiya A, Tanosaki R . Allogeneic stem cell transplantation for adult T-cell leukemia\/lymphoma. Int J Hematol 2007; 86: 118\u2013125.","journal-title":"Int J Hematol"},{"key":"BFbmt2016154_CR95","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1182\/blood-2010-10-312926","volume":"117","author":"Na Gillet","year":"2011","unstructured":"Gillet Na, Malani N, Melamed A, Gormley N, Carter R, Bentley D et al. The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones. Blood 2011; 117: 3113\u20133122.","journal-title":"Blood"},{"key":"BFbmt2016154_CR96","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1182\/blood-2014-02-553602","volume":"123","author":"LB Cook","year":"2014","unstructured":"Cook LB, Melamed A, Niederer H, Valganon M, Laydon D, Foroni L et al. The role of HTLV-1 clonality, proviral structure, and genomic integration site in adult T-cell leukemia\/lymphoma. Blood 2014; 123: 3925\u20133931.","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2016154.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2016154","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2016154.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T09:04:45Z","timestamp":1661245485000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2016154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,12]]},"references-count":96,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["BFbmt2016154"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2016.154","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,12]]},"assertion":[{"value":"21 December 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}